Carey Oconnor Kolaja - Net Worth and Insider Trading
Carey Oconnor Kolaja Net Worth
The estimated net worth of Carey Oconnor Kolaja is at least $68,397 dollars as of 2024-11-13. Carey Oconnor Kolaja is the Director of Revance Therapeutics Inc and owns about 16,561 shares of Revance Therapeutics Inc (RVNC) stock worth over $68,397. Details can be seen in Carey Oconnor Kolaja's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carey Oconnor Kolaja has not made any transactions after 2023-06-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Carey Oconnor Kolaja
Carey Oconnor Kolaja Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carey Oconnor Kolaja owns 1 companies in total, including Revance Therapeutics Inc (RVNC) .
Click here to see the complete history of Carey Oconnor Kolaja’s form 4 insider trades.
Insider Ownership Summary of Carey Oconnor Kolaja
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2023-06-15 | director |
Carey Oconnor Kolaja Latest Holdings Summary
Carey Oconnor Kolaja currently owns a total of 1 stock. Carey Oconnor Kolaja owns 16,561 shares of Revance Therapeutics Inc (RVNC) as of June 15, 2023, with a value of $68,397.
Latest Holdings of Carey Oconnor Kolaja
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2023-06-15 | 16,561 | 4.13 | 68,397 |
Holding Weightings of Carey Oconnor Kolaja
Carey Oconnor Kolaja Form 4 Trading Tracker
According to the SEC Form 4 filings, Carey Oconnor Kolaja has made a total of 1 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Revance Therapeutics Inc is the sale of 2,500 shares on June 15, 2023, which brought Carey Oconnor Kolaja around $70,600.
Insider Trading History of Carey Oconnor Kolaja
- 1
Carey Oconnor Kolaja Trading Performance
Carey Oconnor Kolaja Ownership Network
Ownership Network List of Carey Oconnor Kolaja
Ownership Network Relation of Carey Oconnor Kolaja
Carey Oconnor Kolaja Owned Company Details
What does Revance Therapeutics Inc do?
Who are the key executives at Revance Therapeutics Inc?
Carey Oconnor Kolaja is the director of Revance Therapeutics Inc. Other key executives at Revance Therapeutics Inc include Chief Financial Officer Tobin Schilke , President Dustin S Sjuts , and SVP & GC & Secretary Dwight Moxie .
Revance Therapeutics Inc (RVNC) Insider Trades Summary
Over the past 18 months, Carey Oconnor Kolaja made 1 insider transaction in Revance Therapeutics Inc (RVNC) with a net sale of 2,500. Other recent insider transactions involving Revance Therapeutics Inc (RVNC) include a net sale of 124,284 shares made by Mark J Foley , a net sale of 35,664 shares made by Tobin Schilke , and a net sale of 64,379 shares made by Dwight Moxie .
In summary, during the past 3 months, insiders sold 0 shares of Revance Therapeutics Inc (RVNC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 294,445 shares of Revance Therapeutics Inc (RVNC) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 264,445 shares.
Revance Therapeutics Inc (RVNC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Revance Therapeutics Inc Insider Transactions
Carey Oconnor Kolaja Mailing Address
Above is the net worth, insider trading, and ownership report for Carey Oconnor Kolaja. You might contact Carey Oconnor Kolaja via mailing address: C/o Revance Therapeutics, Inc, 1222 Demonbreun Street, Suite 1001, Nashville Tn 37203.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
